Showing results (191-200 of 199) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Journal of Healthcare Engineering|May 15, 2018
A Deep Belief Network and Dempster-Shafer-Based Multiclassifier for the Pathology Stage of Prostate CancerJae Kwon Kim, Mun Joo Choi, Jong Sik Lee, et al.Medicine|October 19, 2018
Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registryYoon Soo Hah, Kwang Suk Lee, In Young Choi, et al.Scientific Reports|March 7, 2017
Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational studySung Han Kim, Jae Young Joung, Sohee Kim, et al.Korean Journal of Urology|April 25, 2013
The Establishment of K-CaP (the Multicenter Korean Prostate Cancer Database)Dong Hoon Lee, Seung Hwan Lee, Koon Ho Rha, et al.Scientific Reports|July 1, 2024
Comparison of digital and analog [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT for detecting post-prostatectomy biochemical recurrence in prostate cancer patients: a prospective studyYong-Il Kim, Dong Yun Lee, Changhwan Sung, et al.Cancer Science|March 18, 2025
Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset AnalysisMototsugu Oya, Jae Young Joung, Ji Youl Lee, et al.Investigative and Clinical Urology|January 17, 2020
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world settingSeung Il Jung, Myung Soo Kim, Chang Wook Jeong, et al.Cancer Research and Treatment|December 8, 2023
Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus without Confirmatory Bone ScanChang Wook Jeong, Jang Hee Han, Dong Deuk Kwon, et al.Investigative and Clinical Urology|September 2, 2025
Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi studyJae Young Joung, In Gab Jeong, Sung Gu Kang, et al.Pageof 20